Baumer (BALM4) Stock Overview
Engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area in Brazil and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
BALM4 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Baumer S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$16.00 |
| 52 Week High | R$25.00 |
| 52 Week Low | R$14.67 |
| Beta | 0.41 |
| 1 Month Change | -5.83% |
| 3 Month Change | -12.52% |
| 1 Year Change | 3.23% |
| 3 Year Change | 63.27% |
| 5 Year Change | -15.79% |
| Change since IPO | 5,243.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| BALM4 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | -1.8% | 2.6% | 2.1% |
| 1Y | 3.2% | -13.4% | 18.3% |
Return vs Industry: BALM4 exceeded the BR Medical Equipment industry which returned -13.5% over the past year.
Return vs Market: BALM4 underperformed the BR Market which returned 20% over the past year.
Price Volatility
| BALM4 volatility | |
|---|---|
| BALM4 Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 7.8% |
| 10% least volatile stocks in BR Market | 1.9% |
Stable Share Price: BALM4 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: BALM4's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | n/a | Ruy Salvari Baumer | www.baumer.com.br |
Baumer S.A., together with its subsidiaries, engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area in Brazil and internationally. The company offers orthopedic devices, such as conventional prosthesis, spine and neurosurgery, non-conventional prosthesis, trauma, and biomaterials; and hospital equipment, including CSSD, surgical center and ICU, and sterilization process monitoring. It also provides life science equipment comprising pharmaceutical production and research laboratory; bone regeneration consisting of structural, raw material, and specialties; and maintenance, sterilization process monitoring, rental, CME equipment management, technological update, and replacement parts, as well as inspection, qualification, and calibration services.
Baumer S.A. Fundamentals Summary
| BALM4 fundamental statistics | |
|---|---|
| Market cap | R$205.43m |
| Earnings (TTM) | R$19.26m |
| Revenue (TTM) | R$212.37m |
Is BALM4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BALM4 income statement (TTM) | |
|---|---|
| Revenue | R$212.37m |
| Cost of Revenue | R$78.26m |
| Gross Profit | R$134.11m |
| Other Expenses | R$114.85m |
| Earnings | R$19.26m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.97 |
| Gross Margin | 63.15% |
| Net Profit Margin | 9.07% |
| Debt/Equity Ratio | 13.8% |
How did BALM4 perform over the long term?
See historical performance and comparisonDividends
Does BALM4 pay a reliable dividends?
See BALM4 dividend history and benchmarks| Baumer dividend dates | |
|---|---|
| Ex Dividend Date | May 04 2026 |
| Dividend Pay Date | Dec 30 2026 |
| Days until Ex dividend | 93 days |
| Days until Dividend pay date | 147 days |
Does BALM4 pay a reliable dividends?
See BALM4 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/05 09:27 |
| End of Day Share Price | 2026/08/04 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Baumer S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.